The release of Tirzepatide at a 45mg level represents a notable development in treating diabetes. Before, lower doses were commonly prescribed, but this new formulation delivers the possibility for improved glucose control in some patients. Clinicians are assessing its effectiveness and security profile, particularly in individuals who haven’t r… Read More